---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284643230.md"
description: "MiMedx Group shares are trading lower after the company reported worse-than-expected Q1 financial results and lowered its FY2026 sales guidance."
datetime: "2026-04-29T20:53:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284643230.md)
  - [en](https://longbridge.com/en/news/284643230.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284643230.md)
---

# 

MiMedx Group shares are trading lower after the company reported worse-than-expected Q1 financial results and lowered its FY2026 sales guidance.

### Related Stocks

- [MDXG.US](https://longbridge.com/en/quote/MDXG.US.md)

## Related News & Research

- [23:01 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG](https://longbridge.com/en/news/286499871.md)
- [Citizens Jmp Reaffirms "Market Outperform" Rating for MiMedx Group (NASDAQ:MDXG)](https://longbridge.com/en/news/283357487.md)
- [Scientific Industries Reports First Quarter Fiscal 2026 Results | SCND Stock News](https://longbridge.com/en/news/286621365.md)
- [Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update | ARMP Stock News](https://longbridge.com/en/news/286313203.md)
- [Arrowhead Pharmaceuticals Eyes Q3 SHASTA Data as REDEMPLO Approvals Build Momentum](https://longbridge.com/en/news/287080808.md)